Laparoscopic versus open total mesorectal excision for rectal cancer

Area of Science:

• Colorectal Surgery
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• The oncological safety of laparoscopic surgery for rectal cancer is debated due to a lack of definitive long-term data.
• Laparoscopic total mesorectal excision (LTME) offers potential short-term advantages over open total mesorectal excision (OTME).

Purpose of the Study:

• To compare the safety and efficacy of elective LTME versus OTME for rectal cancer resection.
• To identify differences in oncological outcomes and short-term recovery between LTME and OTME.

Main Methods:

• A systematic search of MEDLINE, EMBASE, CENTRAL, and Current Contents (1990-2005) was performed.
• Included studies comprised randomized controlled trials (RCTs), controlled clinical trials, and case series comparing LTME with OTME.
• Study quality was assessed using Oxford Centre for Evidence-based Medicine guidelines; meta-analysis was limited due to study design.

Main Results:

• 48 studies with 4224 patients met inclusion criteria, mostly of poor methodological quality.
• No significant differences were found in disease-free survival, local recurrence, mortality, morbidity, anastomotic leakage, resection margins, or lymph node recovery.
• LTME demonstrated advantages including less blood loss, faster return to diet, reduced pain, lower narcotic use, and less immune response, but with longer operative times and higher costs.

Conclusions:

• LTME appears to offer clinically significant short-term benefits for patients with resectable rectal cancer, based primarily on non-randomized evidence.
• Long-term oncological outcomes require further evaluation through large, ongoing randomized trials.